About
Biovault Technical
Our Mission
Our Team
Facilities
Biovault Family
Quality
Accreditations
Advisory Board
Partnerships
Testimonials
Services
Cellular Therapy Processing
Biobanking
Allografts
Support services
Consultancy
Contingency Planning & Business Continuity
Insights
All
Cellular Therapies
Company News
Educational Resources
Ethical Approach
Industry Events
Innovation
Quality & Safety
Regulatory Compliance
Sustainability
Get in touch

Biovault Technical

About
Biovault Technical
Our Mission
Our Team
Facilities
Biovault Family
Quality
Accreditations
Advisory Board
Partnerships
Testimonials
Services
Cellular Therapy Processing
Biobanking
Allografts
Support services
Consultancy
Contingency Planning & Business Continuity
Insights
All
Cellular Therapies
Company News
Educational Resources
Ethical Approach
Industry Events
Innovation
Quality & Safety
Regulatory Compliance
Sustainability
Get in touch
8 September 2026
Quality & Safety, Regulatory Partnerships
Sarah Conway
What can fertility care learn from the Ovom ...

What can fertility care learn from the Ovom Care insolvency? Explore how robust processing, storage and contingency planning can protect patients and precious biological material.

What can fertility care learn from the Ovom Care insolvency?
25 August 2026
Date Security, Regulatory Partnerships
Sarah Conway
Clinical-grade data security: Protecting ...

Biovault Technical operates a clinical-grade data security model tailored for advanced therapies and biological storage. By integrating annual NHS Information Governance, HTA standards, and Cyber Essentials Plus compliance with a centralised LIMS, Biovault ensures complete data integrity, donor traceability, and cyber resilience across every stage of tissue processing and storage.

Clinical-grade data security: Protecting patient data in complex regulatory environments
25 June 2026
Cellular Therapies, Quality & Safety
Sarah Conway
What happens after a stem cell donor says yes

Explore the zero-margin-for-error custody chain in PBSC processing. Learn how Biovault Technical meets HTA and JACIE standards to ensure transplant viability.

What happens after a stem cell donor says yes
19 May 2026
Cellular Therapies, Innovation
Sarah Conway
Beyond Oncology: The landmark cellular therapy ...

To mark Clinical Trials Day, we explore 5 landmark international trials redefining cellular therapy. From record-breaking oncology survival data to functional cures for severe autoimmunity and HIV, discover the breakthroughs transforming medicine from the lab to the bedside.

Beyond Oncology: The landmark cellular therapy trials redefining modern medicine
6 May 2026
Quality & Safety, Regulatory Partnerships, Cellular Therapies, Innovation, Ethical Practices
Sarah Conway
Donor lymphocyte infusions: from reactive ...

Donor lymphocyte infusions (DLI) and clinical readiness. Discover Biovault’s pre-prepared DLI processing and storage approach for faster access and reduced risk.

Donor lymphocyte infusions: from reactive intervention to clinical readiness
Sarah Conway
5 December 2024
Regulatory Partnerships, Cellular Therapies, Innovation

Biovault Technical Achieves Milestone with MHRA Wholesale Dealers Authorisation

Sarah Conway
5 December 2024
Regulatory Partnerships, Cellular Therapies, Innovation
Biovault Technical Achieves Milestone with MHRA Wholesale Dealers Authorisation

The MHRA has granted Biovault Technical a WDA license, enabling the distribution of medicinal products and advancing cell therapy access in Plymouth and the UK.

Sarah Conway
25 October 2024
Company News, Innovation

Redefining our bioresourceful business

Sarah Conway
25 October 2024
Company News, Innovation
Redefining our bioresourceful business

Biovault is more than a biobank. We are a bioresource offering stem cell processing, allografts, support services and consultancy, as well as biobanking you can trust.

Sarah Conway
9 September 2024
Cellular Therapies, Innovation

Lab-grown HSCs expand the future of cell therapy, and biobanking

Sarah Conway
9 September 2024
Cellular Therapies, Innovation
Lab-grown HSCs expand the future of cell therapy, and biobanking

Lab-grown stem cells may revolutionise cancer treatment by reducing the need for donors. What does this mean for bioresources like Biovault? 

Sarah Conway
23 July 2024
Ethical Practices, Innovation, Sustainability, Educational Resources

Biovault Reduces, Reuses, Recycles and Inspires in Bid to Combat Plastics & Waste

Sarah Conway
23 July 2024
Ethical Practices, Innovation, Sustainability, Educational Resources
Biovault Reduces, Reuses, Recycles and Inspires in Bid to Combat Plastics & Waste

The UK healthcare sector produces hundreds of thousands of tonnes of waste every year. At Biovault, we’re working to reduce waste in every area and have been inspired by the difference it makes.

Sarah Conway
29 May 2024
Industry Events, Company News, Cellular Therapies

EBMT Round up: 5 Key Takeaways from Glasgow 2024

Sarah Conway
29 May 2024
Industry Events, Company News, Cellular Therapies
EBMT Round up: 5 Key Takeaways from Glasgow 2024

EBMT 2024 was an inspiring event combining a patient-first ethos with insights from cellular therapy pioneers. We share our Top 5 Takeaways.

Sarah Conway
22 April 2024
Quality & Safety, Regulatory Partnerships

Preventing catastrophic failure in biobank systems

Sarah Conway
22 April 2024
Quality & Safety, Regulatory Partnerships
Preventing catastrophic failure in biobank systems

Following the publication of a report on the devastating cryogenic freezer failure at the Karolinska Institutet (KI) in Sweden in December 2023, we scrutinise our systems and offer some support. 

Newer Posts
Older Posts
Back to Top
Biovault Technical Ltd, Plymouth International Medical & Technology Park, 24 Brest Road, Derriford, Plymouth, PL6 5XP, United Kingdom+44 1752 753720info@biovaulttechnical.co.uk

address

Biovault Technical
24 Brest Road
Plymouth, PL6 5XP
View on map

TELEPHONE

+44 (0)1752 753720

enquiries

info@biovaulttechnical.co.uk

careers

COOKIE POLICY

Privacy Policy

CONTACT